Irbesartan Amarox

Irbesartan, the active ingredient in Irbesartan Amarox, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is used to treat hypertension and to protect kidney function in patients with diabetic nephropathy. Irbesartan selectively blocks AT1 receptors, reducing vasoconstriction and aldosterone release, which helps lower blood pressure and slows progression of renal damage.

GNH USA supplies Irbesartan Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export.

Irbesartan acts on the renin‑angiotensin‑aldosterone system to control high blood pressure and protect kidney function.

Hypertension: lowers systolic and diastolic blood pressure, improving cardiovascular risk profile. Diabetic nephropathy: slows decline of glomerular filtration rate and reduces proteinuria in type 2 diabetes. Proteinuria: decreases urinary protein excretion, contributing to renal protection.

Common and serious adverse reactions have been reported with irbesartan use.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Back pain - Mild increase in serum creatinine

Serious or Rare Side Effects: - Angioedema - Severe hyperkalemia - Acute renal failure - Hepatic injury - Neutropenia

When prescribing irbesartan, clinicians should consider several safety measures.

Blood pressure monitoring: check regularly to avoid hypotension. Renal function assessment: evaluate serum creatinine and eGFR before and during therapy. Serum potassium: monitor for hyperkalemia, especially with potassium‑sparing agents. Drug contraindications: avoid in patients with known hypersensitivity to irbesartan or other ARBs. Pregnancy and lactation: use only if benefits outweigh risks; not recommended in the second and third trimesters. Store at room temperature: keep in the original container, protect from moisture and light.

Irbesartan may interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone) – risk of hyperkalemia. - ACE inhibitors or aliskiren in diabetic patients – additive renal effects. - NSAIDs – may blunt antihypertensive effect and impair renal function. - Concomitant use with other ARBs – no additional benefit, increased risk of adverse events.

Moderate Interactions (Monitor Closely): - Lithium – irbesartan may increase lithium levels. - Cyclosporine – may raise serum creatinine. - Thiazide diuretics – may enhance hypotensive effect.